Fesults of the failure to perform adequate preclinical studies before administering new drugs to humans
Nestor, J.O.
South African Medical Journal 49(8): 287-290
1975
ISSN/ISBN: 0256-9574 PMID: 47186 Document Number: 95035
Document emailed within 1 workday
Related Documents
Bugelski, P.J.; Treacy, G. 2004: Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans Current Opinion in Molecular Therapeutics 6(1): 10-16Stuart, M.; Frogge, M.H. 1982: Sequence of administering vesicant cytotoxic drugs Oncology Nursing Forum 9(1): 53-54
Decloedt, E.; Maartens, G. 2009: Pitfalls of administering drugs via nasogastric tubes South African Medical Journal 99(3): 148-149
McGettrick, S.; Rodgers, J. 1996: Cost of administering controlled drugs in a hospice ward Health Bulletin 54(6): 441-442
Karski, J.; Krzywiński, R.; Pycz-Pyczewski, M. 1973: The risk of shortening preoperative preparations in patients with pulmonary tuberculosis by administering modern antitubercular drugs--early results Polski Przeglad Chirurgiczny 45(7): 989-995
Stramba-Badiale, M. 1981: The use of drugs in patients over 80. Adequate prescriptions? Minerva Medica 72(47): 3209-3210
Seibel-Seamon, J.; Visintine, J.F.; Leiby, B.E.; Weinstein, L. 2009: Factors predictive for failure to perform postpartum tubal ligations following vaginal delivery Journal of Reproductive Medicine 54(3): 160-164
Epple, O. 2000: Therapy recommendation doesn't make sense: should heart failure patients perform physical exercise? MMW Fortschritte der Medizin 142(31-32): 14
Ammann, P.; Rizzoli, R.; Bonjour, J.P. 1999: Animal models for the preclinical testing of drugs against osteoporosis Revue du Rhumatisme 66(11): 532-533
Sokolova, G.B.; Kunichan, A.D.; Shubin, A.I. 1991: Organization of the work of the Republican Center for Preclinical Study of new Drugs Problemy Tuberkuleza 9: 27-29
Holme, I. 1990: Should we perform long-term cohort studies on the use of antihypertensive agents? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(21): 2801-2802
Overton, D.A. 1979: Preclinical measurement of the amount of state-dependent learning produced by psychoactive drugs Psychopharmacology Bulletin 15(2): 51-52
Nguyen, C.; Pan, J.; Charles, M.A. 1998: Preclinical studies of glimepiride Drugs of Today 34(5): 391-400
Reddy, D.S. 1998: Preclinical and clinical behavioral paradigms for testing drugs that affect learning and memory processes Methods and Findings in Experimental and Clinical Pharmacology 20(3): 249-277
Jourdan, C.; Convert, J.; Peloux, A.; Boussaid, O.; Grando, J.; Tigaud, S. 1996: Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis Pathologie-Biologie 44(5): 389-392
Veselý, J.; Cihák, A. 1980: 5-Aza-2'-deoxycytidine: preclinical studies in mice Neoplasma 27(2): 113-119
Rao, R.R. 1974: Preclinical toxicity studies on Sintamil Indian Journal of Experimental Biology 12(3): 252-256
Schaub, R.; Garzone, P.; Bouchard, P.; Rup, B.; Keith, J.; Brinkhous, K.; Larsen, G. 1998: Preclinical studies of recombinant factor IX Seminars in Hematology 35(2 Suppl 2: 28-32
Fujita, M.; Fujita, F.; Sakamoto, Y.; Sugimoto, T.; Shimozuma, K.; Taguchi, T. 1991: Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(9): 1429-1437
Storniolo, A.M.; Allerheiligen, S.R.; Pearce, H.L. 1997: Preclinical, pharmacologic, and phase i studies of gemcitabine Seminars in Oncology 24(2 Suppl 7: S7